Ketamine Works in OCD, Stubborn Depression
May 21, 2013
SAN FRANCISCO — The anesthetic agent ketamine continues to show tantalizing promise in psychiatric disorders, with results from new studies in intractable depression and obsessive-compulsive disorder (OCD).
In a 72-patient randomized trial involving patients with major depression who had not responded to standard therapies, mean scores on the Montgomery-Asberg Depression Rating Scale (MADRS) fell by half 1 day after an intravenous infusion with ketamine, significantly more than in an “active placebo” group receiving the benzodiazepine agent midazolam.…